Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Pulmonary toxicity associated with sirolimus following kidney transplantation: computed tomography findings.

Davaus Gasparetto T, Marchiori E, Menezes P, Zanetti G.

Nefrologia. 2010;30(2):259-60. doi: 10.3265/Nefrologia.pre2010.Mar.10339. No abstract available.

2.

Conversion to sirolimus.

Ruiz JC, Alonso A, Arias M, Campistol JM, González Molina M, González Posada JM, Grinyo JM, Morales JM, Oppenheimer F, Sánchez Fructuoso A, Sánchez-Plumed J.

Nefrologia. 2006;26 Suppl 2:52-63. Review. English, Spanish. No abstract available.

3.

Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.

Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL 2nd, Kobashigawa J.

Circulation. 2004 Dec 21;110(25):3858-65. Review. No abstract available.

4.

Sirolimus use in de "novo renal" transplantation.

Grinyo JM, Alonso A, Arias M, Campistol JM, González Molina M, González Posada JM, Morales JM, Oppenheimer F, Sánchez Fructuoso A, Sánchez-Plumed J, Ruiz JC.

Nefrologia. 2006;26 Suppl 2:33-51. Review. English, Spanish. No abstract available.

5.

[Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case].

Martínez M, González Roncero FM, López M, Toro J, Valdivia MA, Pereira P, Gentil MA, Rodríguez Algarra G, Mateos J.

Nefrologia. 2004;24 Suppl 3:7-10. Spanish.

6.

Reduced exposure to calcineurin inhibitors in renal transplantation.

Ekberg H, Tedesco-Silva H, Demirbas A, Vítko S, Nashan B, Gürkan A, Margreiter R, Hugo C, Grinyó JM, Frei U, Vanrenterghem Y, Daloze P, Halloran PF; ELITE-Symphony Study.

N Engl J Med. 2007 Dec 20;357(25):2562-75.

7.

Sirolimus may not cause neurotoxicity in kidney and liver transplant recipients.

Maramattom BV, Wijdicks EF.

Neurology. 2004 Nov 23;63(10):1958-9. Review.

PMID:
15557524
8.

Balancing efficacy and toxicity in kidney-transplant immunosuppression.

Leichtman AB.

N Engl J Med. 2007 Dec 20;357(25):2625-7. No abstract available.

PMID:
18094383
9.

Case report: sirolimus associated interstitial lung disease.

Sajjad I, Murthy MH, Nazir J, Santella RN.

S D Med. 2006 Nov;59(11):467-9, 471. No abstract available.

PMID:
17180843
10.

Summaries for patients. Twenty-four cases of pneumonitis in kidney transplantation recipients receiving sirolimus.

[No authors listed]

Ann Intern Med. 2006 Apr 4;144(7):I45. No abstract available.

PMID:
16585659
11.

A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year.

Mendez R, Gonwa T, Yang HC, Weinstein S, Jensik S, Steinberg S; Prograf Study Group.

Transplantation. 2005 Aug 15;80(3):303-9.

PMID:
16082323
12.

[Evidences in immunosuppression in the maintenance of renal transplantation].

Hernández D, González-Posada JM.

Nefrologia. 2005;25(4):369-80. Review. Spanish. No abstract available.

13.

Preliminary immunosuppression withdrawal strategies with sirolimus in children with liver transplants.

Sindhi R, Ganjoo J, McGhee W, Mazariegos G, Reyes J.

Transplant Proc. 2002 Aug;34(5):1972-3. No abstract available.

PMID:
12176651
14.

Steroid withdrawal in renal transplant recipients.

Oppenheimer F.

Transplant Proc. 2000 Feb;32(1A Suppl):14S-15S. No abstract available.

PMID:
10686314
15.

[Reversible posterior leukoencephalopathy induced by tacrolimus in a renal transplant patient].

Izquierdo Pajuelo MJ, Jiménez Delgado JD, Rangel Mayoral JF, Liso Rubio FJ.

Farm Hosp. 2009 May-Jun;33(3):177-8. Spanish. No abstract available.

PMID:
19712604
16.

[Immunomodulation in penetrating keratoplasty. Current status and perspectives].

Pleyer U.

Ophthalmologe. 2003 Dec;100(12):1036-44. Review. German.

PMID:
14704816
17.

Reduced exposure to calcineurin inhibitors in renal transplantation.

Guba M, Jauch KW.

N Engl J Med. 2008 Jun 5;358(23):2518; author reply 2519-20. doi: 10.1056/NEJMc080067. No abstract available.

18.

[Chronic inflammatory bowel diseases].

Herrlinger K, Stange EF.

Dtsch Med Wochenschr. 2004 Oct 15;129(42):2241-50; quiz 2251-4. Review. German. No abstract available.

PMID:
15529447
19.

[The first experience with sirolimus (Rapamune) after kidney transplantation in Lithuania].

Asakiene E, Rainiene T, Dainys B.

Medicina (Kaunas). 2005;41 Suppl 1:93-100. Lithuanian.

20.

Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus.

Dean PG, Lund WJ, Larson TS, Prieto M, Nyberg SL, Ishitani MB, Kremers WK, Stegall MD.

Transplantation. 2004 May 27;77(10):1555-61.

PMID:
15239621

Supplemental Content

Support Center